EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 21 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $41,000 | – | 18,174 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sassicaia Capital Advisers LLC | 25,000 | $56,000 | 0.16% |
| Tuttle Capital Management, LLC | 18,174 | $41,000 | 0.05% |
| XTX Topco Ltd | 13,867 | $31,000 | 0.01% |
| Sterling Financial Planning, Inc. | 1,171 | $3,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 13,832 | $31,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,000 | $2,000 | 0.00% |
| JANE STREET GROUP, LLC | 34,742 | $78,000 | 0.00% |
| UBS Group AG | 399 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,468 | $3,000 | 0.00% |
| US BANCORP \DE\ | 2,710 | $6,000 | 0.00% |